{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:50:50Z","timestamp":1791355850099,"version":"4.3.1"},"reference-count":44,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammation is involved in the initiation and progression of several chronic lymphoid malignancies of B-cell type. Toll-like receptors (TLR) are transmembrane inflammatory receptors that on recognition of pathogen-associated molecular patterns trigger an innate immune response and bridge the innate and adaptive immune response by acting as costimulatory signals for B cells. Fine tuning of TLR and IL-1R\u2013like (ILR) activity is regulated by TIR8 (SIGIRR), a transmembrane receptor of the TLR\/ILR family which inhibits other family members. To test the hypothesis that TLR and\/or ILR may play a role in the natural history of chronic B-cell tumors, we crossed E\u03bc-TCL1 transgenic mice, a well established model of chronic lymphocytic leukemia (CLL), with mice lacking the inhibitory receptor TIR8 that allow an unabated TLR-mediated stimulation. We here report that in the absence of TIR8 the appearance of monoclonal B-cell expansions is accelerated and mouse life span is shortened. The morphology and phenotype of the mouse leukemic expansions reproduce the progression of human CLL into an aggressive and frequently terminal phase characterized by the appearance of prolymphocytes. This study reveals an important pathogenetic implication of TLR in CLL development and progression.<\/jats:p>","DOI":"10.1182\/blood-2011-01-329870","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T00:30:35Z","timestamp":1307493035000},"page":"660-669","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":43,"title":["Lack of TIR8\/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models"],"prefix":"10.1182","volume":"118","author":[{"given":"Maria Teresa Sabrina","family":"Bertilaccio","sequence":"first","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Simonetti","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"},{"name":"Universit\u00e0 degli Studi di Milano-Bicocca, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Dagklis","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rocchi","sequence":"additional","affiliation":[{"name":"Pathology Unit, San Raffaele Scientific Institute, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Veliz","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Apollonio","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"},{"name":"Vita-Salute San Raffaele University, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Inflammation, Istituto Clinico Humanitas, IRCCS, Rozzano, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Pathology Unit, San Raffaele Scientific Institute, Milano, Italy;"},{"name":"Clinical Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"},{"name":"Vita-Salute San Raffaele University, Milano, Italy;"},{"name":"Clinical Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Inflammation, Istituto Clinico Humanitas, IRCCS, Rozzano, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Caligaris-Cappio","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"},{"name":"Vita-Salute San Raffaele University, Milano, Italy;"},{"name":"Clinical Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Muzio","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7203","key":"2019111808254712400_B1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"10","key":"2019111808254712400_B2","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1080\/10428190903115410","article-title":"The role of Toll-like receptors in chronic B cell malignancies.","volume":"50","author":"Muzio","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2019111808254712400_B3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/09680519010070041301","article-title":"Toll-like receptors (TLRs) signalling and expression pattern.","volume":"7","author":"Muzio","year":"2001","journal-title":"J Endotoxin Res"},{"key":"2019111808254712400_B4","first-page":"3111","article-title":"TLR signaling.","author":"Akira","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"2019111808254712400_B5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1034\/j.1398-9995.2001.056002103.x","article-title":"The Toll receptor family.","volume":"56","author":"Muzio","year":"2001","journal-title":"Allergy"},{"issue":"3","key":"2019111808254712400_B6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.coi.2007.04.002","article-title":"Toll-like receptors and innate immunity in B-cell activation and antibody responses.","volume":"19","author":"Lanzavecchia","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2019111808254712400_B7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood-2002-11-3355","article-title":"The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.","volume":"102","author":"Bourke","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2019111808254712400_B8","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1182\/blood-2002-11-3569","article-title":"A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.","volume":"101","author":"Bernasconi","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111808254712400_B9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/eji.200535744","article-title":"Toll-like receptor stimulation as a third signal required for activation of human naive B cells.","volume":"36","author":"Ruprecht","year":"2006","journal-title":"Eur J Immunol"},{"issue":"6881","key":"2019111808254712400_B10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"issue":"9","key":"2019111808254712400_B11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.20050630","article-title":"RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement.","volume":"202","author":"Lau","year":"2005","journal-title":"J Exp Med"},{"issue":"10","key":"2019111808254712400_B12","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1073\/pnas.0308680101","article-title":"Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family.","volume":"101","author":"Garlanda","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111808254712400_B13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni968","article-title":"SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.","volume":"4","author":"Wald","year":"2003","journal-title":"Nat Immunol"},{"issue":"9","key":"2019111808254712400_B14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.it.2009.06.001","article-title":"TIR8\/SIGIRR: an IL-1R\/TLR family member with regulatory functions in inflammation and T cell polarization.","volume":"30","author":"Garlanda","year":"2009","journal-title":"Trends Immunol"},{"issue":"13","key":"2019111808254712400_B15","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1158\/0008-5472.CAN-07-0560","article-title":"Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family.","volume":"67","author":"Garlanda","year":"2007","journal-title":"Cancer Res"},{"issue":"4","key":"2019111808254712400_B16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2007.02.012","article-title":"The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.","volume":"26","author":"Xiao","year":"2007","journal-title":"Immunity"},{"issue":"2","key":"2019111808254712400_B17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2010.04.043","article-title":"Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.","volume":"139","author":"Xiao","journal-title":"Gastroenterology"},{"issue":"27","key":"2019111808254712400_B18","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1200\/JCO.2007.15.4393","article-title":"Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?","volume":"26","author":"Caligaris-Cappio","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111808254712400_B19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2007.02.014","article-title":"From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.","volume":"7","author":"Ghia","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"6","key":"2019111808254712400_B20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-0609.2008.01069.x","article-title":"Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper.","volume":"80","author":"Dungarwalla","year":"2008","journal-title":"Eur J Haematol"},{"issue":"6","key":"2019111808254712400_B21","first-page":"343","article-title":"Prolymphocytic leukaemia.","volume":"24","author":"Catovsky","year":"1982","journal-title":"Nouv Rev Fr Hematol"},{"issue":"10","key":"2019111808254712400_B22","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"2019111808254712400_B23","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1073\/pnas.0604564103","article-title":"B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.","volume":"103","author":"Yan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2019111808254712400_B24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2008.07475.x","article-title":"Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.","volume":"144","author":"Muzio","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111808254712400_B25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2141.2009.07849.x","article-title":"Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia.","volume":"147","author":"Anderson","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111808254712400_B26","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood-2006-08-044008","article-title":"Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia.","volume":"109","author":"Landgren","year":"2007","journal-title":"Blood"},{"issue":"18","key":"2019111808254712400_B27","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood-2009-12-258814","article-title":"HS1 has a central role in the trafficking and homing of leukemic B cells.","volume":"116","author":"Scielzo","journal-title":"Blood"},{"issue":"4","key":"2019111808254712400_B28","first-page":"211","article-title":"Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8\/SIGIRR.","volume":"14","author":"Polentarutti","year":"2003","journal-title":"Eur Cytokine Netw"},{"issue":"19","key":"2019111808254712400_B29","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood-2009-11-254656","article-title":"MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221\/222 cluster and p27.","volume":"115","author":"Frenquelli","journal-title":"Blood"},{"issue":"4","key":"2019111808254712400_B30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.autrev.2008.11.007","article-title":"CD5: a safeguard against autoimmunity and a shield for cancer cells.","volume":"8","author":"Dalloul","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2019111808254712400_B31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V73.5.1259.1259","article-title":"Human normal CD5+ B lymphocytes can be induced to differentiate to CD5- B lymphocytes with germinal center cell features.","volume":"73","author":"Caligaris-Cappio","year":"1989","journal-title":"Blood"},{"issue":"3","key":"2019111808254712400_B32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/1043-4666(94)90019-1","article-title":"Interleukin 1 (IL-1 alpha and IL-1 beta) induces differentiation\/activation of B cell chronic lymphoid leukemia cells.","volume":"6","author":"Takeuchi","year":"1994","journal-title":"Cytokine"},{"issue":"2","key":"2019111808254712400_B33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/eji.1830190212","article-title":"Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.","volume":"19","author":"Defrance","year":"1989","journal-title":"Eur J Immunol"},{"issue":"9","key":"2019111808254712400_B34","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.4049\/jimmunol.0802412","article-title":"IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.","volume":"182","author":"Garaud","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"2019111808254712400_B35","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.140.12.4180","article-title":"Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive.","volume":"140","author":"Nakamura","year":"1988","journal-title":"J Immunol"},{"issue":"2","key":"2019111808254712400_B36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2567.2008.02832.x","article-title":"The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization.","volume":"125","author":"Xu","year":"2008","journal-title":"Immunology"},{"issue":"9","key":"2019111808254712400_B37","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-06-4067","article-title":"Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling.","volume":"67","author":"Huang","year":"2007","journal-title":"Cancer Res"},{"issue":"13","key":"2019111808254712400_B38","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/emboj.2010.94","article-title":"TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.","volume":"29","author":"Mittal","journal-title":"EMBO J"},{"issue":"8","key":"2019111808254712400_B39","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.4049\/jimmunol.176.8.4894","article-title":"TLR3 can directly trigger apoptosis in human cancer cells.","volume":"176","author":"Salaun","year":"2006","journal-title":"J Immunol"},{"issue":"24","key":"2019111808254712400_B40","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1182\/blood-2009-03-213363","article-title":"Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.","volume":"115","author":"Liang","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111808254712400_B41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI36551","article-title":"Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.","volume":"120","author":"Cherfils-Vicini","year":"2010","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111808254712400_B42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.","volume":"13","author":"Kanzler","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"2019111808254712400_B43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrc2541","article-title":"Toll-like receptors and cancer.","volume":"9","author":"Rakoff-Nahoum","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2019111808254712400_B44","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.leukres.2009.12.020","article-title":"The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.","volume":"34","author":"Tarnani","year":"2010","journal-title":"Leuk Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/3\/660\/1347371\/zh802911000660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/3\/660\/1347371\/zh802911000660.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T03:35:15Z","timestamp":1686108915000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/3\/660\/28968\/Lack-of-TIR8SIGIRR-triggers-progression-of-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,21]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-329870","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,21]]}}}